ADVERTISEMENT
Press release content from NewMediaWire. The AP news staff was not involved in its creation.
Related topics
PRESS RELEASE: Paid content from NewMediaWire
Press release content from NewMediaWire. The AP news staff was not involved in its creation.

GINKGO BIOWORKS UPDATE

October 31, 2021 GMT

Securities Litigation Partner James (Josh) Wilson Encourages Investors Who Suffered Losses Exceeding $50,000 In Ginkgo Bioworks To Contact Him Directly To Discuss Their Options

NEW YORK, NY - ( NewMediaWire ) - October 31, 2021 - Faruqi & Faruqi, LLP, a leading national securities law firm, is investigating potential claims against Ginkgo Bioworks Holdings, Inc. (“Ginkgo Bioworks” or the “Company”) (NYSE: DNA).

If you suffered losses exceeding $50,000 investing in Ginkgo Bioworks stock or options and would like to discuss your legal rights, call Faruqi & Faruqi partner Josh Wilson directly at 877-247-4292 or 212-983-9330 (Ext. 1310). You may also click here for additional information: http://www.faruqilaw.com/DNA.

There is no cost or obligation to you. 

Faruqi & Faruqi is a leading minority and Woman-owned national securities law firm with offices in New York, Delaware, Pennsylvania, California and Georgia.

ADVERTISEMENT


On October 6, 2021, Scorpion Capital published a report about Ginkgo alleging that it is a “colossal scam.” It describes the Company’s business model as a “shell game,” and that the company is highly dependent on related party transaction revenues. The report also calls the company a “Frankenstein mash-up of the worst frauds of the last 20 years.”

On this news, the Company’s share price fell as much as 20%, during intraday trading on October 6, 2021, thereby injuring investors.


Attorney Advertising.  The law firm responsible for this advertisement is Faruqi & Faruqi, LLP (www.faruqilaw.com).  Prior results do not guarantee or predict a similar outcome with respect to any future matter.  We welcome the opportunity to discuss your particular case.  All communications will be treated in a confidential manner.